Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TEMOZOLOMIDE
- Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Study of Olutasidenib and Temozolomide in HGG
- Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
- A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
- Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Azeliragon in MGMT Unmethylated Glioblastoma
- Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
- A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
- Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma
- The Efficacy and Safety of Temozolomide in Patients With MPPGL
- Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
- The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma
- Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma
- Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
- A Study to Evaluate Safety and Efficacy of BEY1107 in Combination With Temozolomide in Patients With Recurrent or Progressive Glioblastoma Multiforme (GBM)
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
- A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Dose Finding Study of [177Lu]Lu-NeoB in Combination With RT and TMZ in Newly Diagnosed GBM.
- HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer
- Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
- A Study of Temodar With PCI-24781 for Patients With Recurrent Glioma
- Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed o6-methylguanine-DNA-methyltransferase (MGMT) Negative Glioblastoma Multiforme (GBM)
- Glutamate Inhibitors in Glioblastoma
- LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
- The Efficacy and Safety of Temozolomide in SDH-deficient GIST
- A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
- Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
- Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
- Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
- Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
- Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
- ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
- 11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
- A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
- Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
- Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
- Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
- Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma
- Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
- Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
- Surgical Pembro +/- Olaparib w TMZ for rGBM
- CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
- Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
- Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
- Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
- Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
- Rapid Administration Pilot for Infusing Dinutuximab
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
- Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
- ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
- A Phase 2 Trial of All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
- A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
- Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
- ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
- Treatment of Primary CNS Lymphoma ( FTD )
- Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
- The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
- Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
- Chlorpromazine and Standard of Care in Glioblastoma
- Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Trial of Dichloroacetate in Glioblastoma
- Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients >= 18 Years Old With Advanced Stage Rare Cancers, RARE 2 Study
- Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
- Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
- Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
- A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
- To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
- A Phase I/II Study of Pembrolizumab and M032 (NSC 733972)
- Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
- hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
- Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
- Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy
- Preoperative Radiosurgery for the Treatment of High Grade Glioma, The NeoGlioma Study
- Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma
- A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
- Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
- Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
- A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM
- Newly Diagnosed Glioblastoma
- Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
- Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
- Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
- Temozolomide and Atezolizumab as Second Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
- Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
- A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
- Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
- A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
- AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
- NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
- Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study
- Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
- Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
- Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
- Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
- Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
- 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
- Study of Niacin in Glioblastoma
- Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
- Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
- Study of Pamiparib in Newly Diagnosed and rGBM
- Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
- TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
- ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
- Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
- Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
- Nedisertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
- A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
- Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
- HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM
- Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
- RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
- Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
- Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
- Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
- A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
- Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
- Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
- Trial of AEO in New Glioblastoma (GBM)
- Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
- Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer
- A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
- Cabozantinib in High Grade Neuroendocrine Neoplasms
- A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer
- Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma
- Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
- Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
- Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
- Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
- Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
- Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
- Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
- NG101m Adjuvant Therapy in Glioblastoma Patients
- Study of Capecitabine-Temozolomide(CapTem) With Yttrium-90 in Patients With Unresectable Metastatic Grade 2 Neuroendocrine Tumors
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary
- A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Subjects With Newly Diagnosed Glioblastoma
- Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
- Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- A Multi-cohort Phase II Study of HER2-positive and Triple-negative Breast Cancer Brain Metastases.
- Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma
- Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
- Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas
- Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma
- Restrictive Use of Dexamethasone in Glioblastoma
- Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas
- 2-OHOA With RT and TMZ for Adults With Glioblastoma
- The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas
- 9-ING-41 in Pediatric Patients With Refractory Malignancies.
- A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors
- Repurposing Chlorpromazine in the Treatment of Glioblastoma
- Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
- NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
- Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
- A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
- Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
- Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
- Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
- TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer
- Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
- Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
- A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
- A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
- Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
- B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
- IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL
- Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
- Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
- Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
- Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
- Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
- Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ
- First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression
- Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
- Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
- Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
- BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
- Pembrolizumab for Newly Diagnosed Glioblastoma
- A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
- Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
- A Study to Evaluate the Safety of 2-OHOA Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
- NVX-108 Combined With Radiation & TMZ, and During Maintenance Phase for Newly-diagnosed Glioblastoma Multiforme
- NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
- Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
- Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
- TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
- HFSRT With Concurrent TMZ for Large BMs
- 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
- A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
- Trial in Low Grade Glioma Patients: Wait or Treat
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
- Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
- TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
- Hyperpolarized Imaging in Diagnosing Participants With Glioma
- Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases
- Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
- Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
- Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
- DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
- rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide
- A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
- Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
- Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
- Treatment Intensification With Temozolomide in Adults With a Glioblastoma
- Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
- A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
- Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter (BORTEM-17)
- Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
- Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)
- OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
- Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
- GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
- Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
- SGT-53 in Children With Recurrent or Progressive CNS Malignancies
- M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
- Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
- CB-839 With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
- Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma
- Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status
- Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
- Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
- Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma
- INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
- Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
- Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
- Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
- Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
- Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
- ABI-009 (Nab-rapamycin) in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
- Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
- Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
- Seizure Prophylaxis Study
- Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
- A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer
- A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma
- UNITE Study: Understanding New Interventions With GBM ThErapy
- Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
- Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
- Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma
- Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
- Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
- CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
- Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
- Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
- Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
- Irinotecan and Temozolomide for Ewing Sarcoma
- Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy
- Two Chemotherapy Regimens Plus or Minus Bevacizumab
- A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
- Phase I EGFR BATs in Newly Diagnosed Glioblastoma
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
- Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
- Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
- 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
- Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
- Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
- [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
- Quality of Life and Neurocognitive Functioning
- Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
- Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
- International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
- A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma
- NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
- Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
- Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
- Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
- A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
- A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
- Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
- T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
- Study of Chemoimmunotherapy for High-Risk Neuroblastoma
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
- Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction
- NCT Neuro Master Match - N²M² (NOA-20)
- Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
- A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
- Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
- VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
- Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
- PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
- Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
- HUMC 1612: Optune NovoTTF-200A System
- BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
- Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial
- TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
- Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
- Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
- Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
- Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
- Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
- Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
- INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
- Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
- Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
- Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas
- MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
- Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
- Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
- Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
- Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
- Feasibility Study on LITT for Newly Diagnosed Glioblastoma
- Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
- RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
- Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
- A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
- Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
- Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
- A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
- A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
- Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
- Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
- European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
- Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
- Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
- Temozolomide Chronotherapy for High Grade Glioma
- Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
- Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
- A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
- CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas
- Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
- Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
- Protocol for the Treatment of Metastatic Ewing Sarcoma
- Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
- Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
- Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin
- Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
- Radiation Therapy and Combination Chemotherapy for Medulloblastoma
- Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
- An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
- Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
- TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
- Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
- Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
- Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
- Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases
- Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
- Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
- mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
- An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
- Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
- Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care
- Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
- Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
- Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
- A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
- Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
- Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
- Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
- A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma
- Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
- Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
- Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
- Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas
- Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas
- A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
- Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
- qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
- Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- The Addition of Chloroquine to Chemoradiation for Glioblastoma,
- Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma
- Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)
- Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
- Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
- Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
- Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
- Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
- The Addition of Chloroquine to Chemoradiation for Glioblastoma
- Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
- DC Migration Study for Newly-Diagnosed GBM
- Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
- Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
- A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
- Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System
- Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
- Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
- A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
- Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
- A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
- Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
- Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
- Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)
- Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
- Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
- Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma
- Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
- Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
- Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Prevention of Thrombocytopenia in Glioblastoma Patients
- A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy
- Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
- A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
- Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- IDH1 Peptide Vaccine for Recurrent Grade II Glioma
- The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
- Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
- Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
- Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
- MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
- A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
- Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma
- Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
- Preoperative Chemoradiation for Glioblastoma
- Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM
- Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
- Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
- Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
- PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
- Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
- ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma
- Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
- Everolimus With and Without Temozolomide in Adult Low Grade Glioma
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
- Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
- 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
- An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
- Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
- A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
- Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
- Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)
- Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure
- Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients
- Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
- Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
- Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
- Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
- A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
- FMISO-PET in Brain Tumors and SCS Effect
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
- Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
- Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
- Valproic Acid in Childhood Progressive Brain Tumors
- A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
- Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
- Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala
- BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
- TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
- Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
- Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
- Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor
- A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
- Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery
- A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
- MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations
- Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
- Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
- A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients
- A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma
- Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
- A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
- Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
- Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
- A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
- A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Bevacizumab Beyond Progression (BBP)
- Procarbazine and Lomustine in Recurrent Glioblastoma
- Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors
- Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
- Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
- A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
- Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)
- Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
- Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
- Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
- Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas
- NOA-12: BIBF1120 and R-RT in Glioblastoma
- Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
- Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
- Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
- An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and P
- Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma
- Study of MLN8237 in Combination With Irinotecan and Temozolomide
- Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
- Doxycycline, Temozolomide and Ipilimumab in Melanoma
- Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
- Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
- Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)
- Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients
- Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion
- Metformin in Children With Relapsed or Refractory Solid Tumors
- Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
- Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
- Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast
- Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
- Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
- Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
- Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
- Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
- Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
- A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- DNA Repair Inhibitor & Irradiation on Melanoma
- Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
- Low Dose Radiation Therapy for Glioblastoma Multiforme
- Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
- Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
- Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
- Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
- Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
- Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
- Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
- PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
- Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
- A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma
- Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
- Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma
- Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
- Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
- Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
- Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
- Metronomic Temozolamide in Patients With Recurrent Glioblastoma
- Low Dose Naltrexone for Glioma Patients
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
- Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
- A Safety Study in Participants With Advanced Solid Tumors
- BG & TMZ Therapy of Glioblastoma Multiforme
- Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
- Temozolomide in Elderly Patients With KPS < 70
- Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
- The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
- Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
- Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
- Dendritic Cell Cancer Vaccine for High-grade Glioma
- Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
- ABT-888 and Temozolomide for Liver Cancer
- Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
- To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
- Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
- Vitamin D for Treatment of Glioblastoma Multiforme
- Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
- Bevacizumab in Recurrent Grade II and III Glioma
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
- Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
- Veliparib and Temozolomide in Treating Patients With Acute Leukemia
- Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
- Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
- High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
- Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
- Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
- Ipilimumab + Temozolomide in Metastatic Melanoma
- A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
- Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
- A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
- TPI 287 in Patients With Recurrent Glioblastoma Multiforme
- Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
- Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
- Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
- Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
- Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
- A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
- APG101 in Glioblastoma
- A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
- Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
- A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer
- Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
- A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
- Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
- Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
- Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
- Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
- A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
- Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment
- Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
- Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
- Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
- Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
- A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
- SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
- Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
- Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
- Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
- Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
- A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
- Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma
- Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
- A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
- Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
- A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
- Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
- Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
- Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas
- Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
- Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors
- Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
- Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
- Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
- MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
- Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
- Treatment Strategy for Low-grade Gliomas
- Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
- A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
- Sorafenib in Newly Diagnosed High Grade Glioma
- Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
- Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
- Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
- Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Capecitabine and Temozolomide for Neuroendocrine Cancers
- TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
- Medical Treatment of "High-Risk" Neurofibromas
- Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
- Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)
- Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
- Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
- Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
- Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
- Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
- Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
- RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
- A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
- A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
- A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
- SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
- ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
- CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
- PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors
- Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
- MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
- Nimotuzumab in Adults With Glioblastoma Multiforma
- Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
- Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
- Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
- Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
- Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
- Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
- A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma
- Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
- Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
- Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
- Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
- Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
- Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
- Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
- Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
- Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
- Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
- Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
- Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
- Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
- Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
- Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
- Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
- O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
- Study of Temzolomide and Gleevec in Advanced Melanoma
- Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
- MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
- A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma
- Dose-Intense Temozolomide in Recurrent Glioblastoma
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
- Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
- Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
- Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)
- Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)
- Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
- Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy
- Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
- Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
- Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
- Temozolomide in Treating Patients With Recurrent High-Grade Glioma
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
- Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
- Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
- Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
- Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
- Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
- PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
- Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
- Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
- Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia
- Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
- Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma
- Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma
- Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
- Temozolomide in Treating Patients With Invasive Pituitary Tumors
- Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
- Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
- Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma
- Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
- Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
- Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
- A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme
- Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases
- RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
- Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
- Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
- Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
- Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
- Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
- Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
- Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
- Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors
- Taxotere/Temodar/Cisplatin Study in Melanoma Patients
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
- Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
- Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
- Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
- VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
- DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
- Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
- Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
- Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
- Biochemotherapy With Temozolomide for Metastatic Melanoma
- 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
- Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
- Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
- Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
- Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
- Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
- Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
- Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
- a Phase II Study in Primary Central Nervous System Lymphoma
- Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
- Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
- O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
- Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
- Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
- Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)
- Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
- Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
- Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
- Abraxane and Temodar Plus Genasense in Advanced Melanoma
- Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
- Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
- Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
- Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
- Epothilone in Recurrent Glioblastoma Patients
- A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
- AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
- Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
- The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
- PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
- Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
- Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
- Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
- Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
- Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
- Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
- Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
- Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
- Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
- Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Temozolomide in Treating Patients With Low-Grade Glioma
- Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
- Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
- Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Temodar and Sutent as Therapy for Melanoma
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
- Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
- Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
- Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma
- Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
- O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
- Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
- A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
- Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
- Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
- Safety and Efficacy of Talampanel in Glioblastoma Multiforme
- Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)
- Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
- CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
- Disulfiram in Patients With Metastatic Melanoma
- Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
- Combination Paclitaxel, Carboplatin and Temozolomide
- Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
- Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
- Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
- Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
- Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
- Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
- Radiation Therapy or Temozolomide in Treating Patients With Gliomas
- Prolonged Daily Temozolomide for Low-Grade Glioma
- Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
- Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma
- Temozolomide and Radiation Therapy in Treating Patients With Gliomas
- Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
- A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
- Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Lonafarnib and Temozolomide in Treating Patients With Glioblastoma Multiforme That Is Recurrent or Did Not Respond to Previous Treatment With Temozolomide
- Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
- Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
- IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
- Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
- Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
- Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
- Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
- Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
- Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
- A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
- Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
- Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
- Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
- Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
- Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
- Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
- Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
- Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
- Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
- Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
- BMS-247550 in Treating Patients With Stage IV Melanoma
- Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
- Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
- Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
- Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
- Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma
- Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
- Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
- Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
- Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
- Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
- Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
- Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
- Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
- Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery
- Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain
- Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer
- Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
- Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
- Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
- Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
- Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
- Temozolomide in Treating Patients With Brain Metastases
- Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
- Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
- Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
- S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
- Temozolomide in Treating Women With Advanced Breast Cancer
- Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
- Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Temozolomide in Treating Patients With Recurrent Malignant Glioma
- Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
- Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
- Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
- Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
- Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
- Chemotherapy in Treating Patients With Advanced Solid Tumors
- Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Temozolomide in Treating Patients With Progressive Low-Grade Glioma
- Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
- Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
- Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
- Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
- Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
Clinical trials list
click for details